# Implementation of PPI Medication PGX Testing

> **NCT02794844** · PHASE4 · COMPLETED · sponsor: **Nemours Children's Clinic** · enrollment: 28 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Genotype Guided PPI Dosing

## Key facts

- **NCT ID:** NCT02794844
- **Lead sponsor:** Nemours Children's Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-21
- **Primary completion:** 2017-01-23
- **Final completion:** 2018-08-31
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02794844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02794844, "Implementation of PPI Medication PGX Testing". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02794844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*